once-weekly semaglutide in adults with overweight or obesity VisualAbstract: Reduces Body Weight People Once-Weekly Semaglutide in Adults with

Fuente: Medical News Today Referencia: Iepsen EW, Lundgren JR, Hartmann B, et al

Research findings are mixed, with some studies linking GLP-1 drugs to higher risks of mental health issues

Several Indian companies are preparing to enter the market: Alkem Laboratories has started clinical trials for semaglutide and plans to launch close to patent expiration in March 2026. Biocon is developing its own version of Wegovy and aims to be one of the early players in the market, targeting a launch in 2026 or shortly after

LIQUID CARNITINE 3000 is highly concentrated and can be combined with other diet products

No smoking or vaping Smoking and vaping both weaken the valve that keeps acid in the stomach and can make reflux much worse